Equities

Kissei Pharmaceutical Co Ltd

Kissei Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)3,495.00
  • Today's Change5.00 / 0.14%
  • Shares traded52.70k
  • 1 Year change+1.01%
  • Beta0.5129
Data delayed at least 20 minutes, as of Sep 19 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments45,93349,59953,152
Total Receivables, Net28,67922,77922,806
Total Inventory26,29622,79818,987
Prepaid expenses------
Other current assets, total3,6435,4654,397
Total current assets104,551100,64199,342
Property, plant & equipment, net24,86124,57924,074
Goodwill, net309----
Intangibles, net1,6831,5071,569
Long term investments106,36174,76996,631
Note receivable - long term5.005.003.00
Other long term assets1,0219681,004
Total assets260,929221,200238,087
LIABILITIES
Accounts payable4,8934,6174,104
Accrued expenses1,8561,6791,721
Notes payable/short-term debt1,3401,4901,640
Current portion long-term debt/capital leases151145116
Other current liabilities, total9,4237,02611,163
Total current liabilities17,66314,95718,744
Total long term debt236317227
Total debt1,7271,9521,983
Deferred income tax21,18810,42616,259
Minority interest1,107914794
Other liabilities, total706686677
Total liabilities40,90027,30036,701
SHAREHOLDERS EQUITY
Common stock24,35624,35624,356
Additional paid-in capital24,22624,22624,226
Retained earnings (accumulated deficit)127,310125,576118,183
Treasury stock - common(13209)(12912)(12912)
Unrealized gain (loss)52,78230,39345,095
Other equity, total4,5642,2612,438
Total equity220,029193,900201,386
Total liabilities & shareholders' equity260,929221,200238,087
Total common shares outstanding444646
Treasury shares - common primary issue5.115.705.70
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.